Andreas Meyer-Lindenberg
Prof. Meyer-Lindenberg is Director of the Central Institute of Mental Health, as well as the Medical Director of the Department of Psychiatry and Psychotherapy at the Institute, based in Mannheim, Germany and Professor and Chair of Psychiatry and Psychotherapy at the University of Heidelberg in Heidelberg, Germany. He is board-certified in psychiatry, psychotherapy, and neurology. Before coming to Mannheim in 2007, he spent ten years as a scientist at the National Institutes of Mental Health, Bethesda, USA.
Prof. Meyer-Lindenberg is the author of more than 440 peer-reviewed articles and book chapters in journals such as Nature, Science, Nature Neuroscience, Nature Medicine, Nature Reviews Neuroscience, Nature Genetics, Neuron, PNAS, and others. He is has been continuously named as one of the most highly cited scientists in the world (www.isihighlycited.com) He is the Editor-in-Chief of the European Journal of Neuropsychopharmacology, associate editor of Science Advances, and on the editorial board of a number of other journals such as Schizophrenia Bulletin, European Neuropsychopharmacology, Psychiatry Research: Neuroimaging, and Neuroimage.
His research interests focus on the development of novel treatments for severe psychiatric disorders, especially schizophrenia, through an application of multimodal neuroimaging, genetics and enviromics to characterize brain circuits underlying the risk for mental illness and cognitive dysfunction.
In recognition of his research, Prof. Meyer-Lindenberg has received awards throughout his career, including the Joel Elkes International Award for Clinical Research from the American College of Neuropsychopharmacology (2006), the A.E. Bennett Award of the Society for Biological Psychiatry (2007), Kurt Schneider Scientific Award (2010), the Hans-Jörg Weitbrecht-Preis für Klinische Neurowissenschaften (2011), the ECNP Neuropsychopharmacology Award, 2012, the Prix ROGER DE SPOELBERCH (2014), and the 2016 CINP Lilly Neuroscience Clinical Research Award (2016).
